Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACMSD | Q8TDX5 | 4/20 | 0.66 |
| ▸ | CA1 | P00915 | 3/20 | 0.66 |
| ▸ | CA2 | P00918 | 3/20 | 0.66 |
| ▸ | MEN1 | O00255 | 3/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | HPGD | P15428 | 2/20 | 0.66 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.66 |
| ▸ | DHFR | P00374 | 2/20 | 0.66 |
| ▸ | USP2 | O75604 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | TTR | P02766 | 1/20 | 0.66 |
| ▸ | ALB | P02768 | 1/20 | 0.66 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.66 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.66 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.66 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29759451 | 1.00 | ACMSD (0.66) | ACMSDCA1CA2MEN1KMT2A | |
| SCHEMBL27405095 | 0.98 | ACMSD (0.64) | ACMSDCA1CA2MEN1KMT2A | |
| Phosphoric Acid SCHEMBL31026334 | 0.92 | ACMSD (0.58) | ACMSDCA1CA2MEN1KMT2A | |
| Phosphoric Acid SCHEMBL8776062 | 0.92 | ACMSD (0.58) | ACMSDCA1CA2MEN1KMT2A | |
| Phosphoric Acid SCHEMBL31026333 | 0.92 | ACMSD (0.58) | ACMSDCA1CA2MEN1KMT2A | |
| SCHEMBL27382597 | 0.87 | MEN1 (0.54) | ACMSDCA1CA2MEN1KMT2A | |
| SCHEMBL330405 | 0.84 | ACMSD (0.72) | ACMSDCA1CA2MEN1KMT2A | |
| SCHEMBL3695268 | 0.82 | ACMSD (0.70) | ACMSDCA1CA2MEN1KMT2A | |
| SCHEMBL3690106 | 0.82 | ACMSD (0.70) | ACMSDCA1CA2MEN1KMT2A | |
| SCHEMBL188203 | 0.82 | ALDH1A1 (0.61) | ACMSDCA1CA2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1086 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125387-A1 | (R)-N-ETHYL-5-FLUORO-N-ISOPROPYL-2-((5-(2-(6-((2-METHOXYETHYL)(METHYL)AMINO)-2-METHYLHEXAN-3-YL)-2,6-DIAZASPIRO[3.4]OCTAN-6-YL)-1,2,4-TRIAZIN-6-YL)OXY)BENZAMIDE BESYLATE SALT | JANSSEN PHARMACEUTICA NV (BE) | 2026-05-07 | — | — | US | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| EP-4352449-B1 | PROJECTILE PAYLOAD FOR TRAINING AMMUNITION WITH MULTI-SPECTRAL OUTPUT | CYALUME TECH INC (US) | 2025-05-07 | — | — | EP | claimed |
| CN-119431706-A | Fatigue-resistant polyurethane elastomer and preparation method and application thereof | 万勋科技(深圳)有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119241604-A | Organic-inorganic hybrid { Ti3In}xCrystalline state titanium indium oxide cluster patterning material and preparation method and application thereof | 中国科学院福建物质结构研究所 | 2025-01-03 | — | — | CN | claimed |
| CN-118619869-B | Halogen-containing lithium ion eutectic crystal and preparation method and application thereof | 佛山大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118852178-A | Compounds for the treatment of diseases such as cancer | 詹森药业有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118405972-B | Preparation method of 5-fluoro salicylic acid | 爱斯特（成都）生物制药股份有限公司 | 2024-09-10 | — | — | CN | claimed |
| CN-118619869-A | Halogen-containing lithium ion eutectic crystal and preparation method and application thereof | 佛山大学 | 2024-09-10 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| US-20050136015-A1 | Topical use of halosalicylic acid derivatives | AVON PRODUCTS, INC. | 2005-06-23 | — | — | US | claimed |
| WO-2005021581-A2 | INDUCERS OF PLANT DISEASE RESISTANCE | VALENT BIOSCIENCES CORPORATION (US) | 2005-03-10 | — | — | WO | claimed |
| US-20050050587-A1 | Inducers of plant disease resistance | VALENT BIOSCIENCES CORPORATION | 2005-03-03 | — | — | US | claimed |
| US-6294186-B1 | Antimicrobial compositions comprising a benzoic acid analog and a metal salt | PROCTER & GAMBLE COMPANY, THR | 2001-09-25 | — | — | US | claimed |
| EP-1018927-A1 | LIGHTING ELEMENT FOR VISUAL OR PHOTOGRAPHIC MEDICAL EXAMINATION | Laboratoires Piette International S.A. (BE) | 2000-07-19 | — | — | EP | claimed |
| WO-1999016342-A1 | LIGHTING ELEMENT FOR VISUAL OR PHOTOGRAPHIC MEDICAL EXAMINATION | LABORATOIRES PIETTE INTERNATIONAL S.A. (BE) | 1999-04-08 | — | — | WO | claimed |
| CN-1199396-A | Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases | HOFFMANN LA ROCHE (CH) | 1998-11-18 | — | — | CN | claimed |
| EP-0836592-A1 | AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 1998-04-22 | — | — | EP | claimed |
| WO-1997002249-A1 | NOVEL AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 1997-01-23 | — | — | WO | claimed |
| US-3997342-A | Photoconductive element exhibiting persistent conductivity | EASTMAN KODAK COMPANY (US) | 1976-12-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136015-A1 | Topical use of halosalicylic acid derivatives | NACA, TYR, PRKDC | ACMSD 1718/4885CA1 3433/4885CA2 2594/4885 |
| US-20260125387-A1 | (R)-N-ETHYL-5-FLUORO-N-ISOPROPYL-2-((5-(2-(6-((2-METHOXYETHYL)(METHYL)AMINO)-2-METHYLHEXAN-3-YL)-2,6-DIAZASPIRO[3.4]OCTAN-6-YL)-1,2,4-TRIAZIN-6-YL)OXY)BENZAMIDE BESYLATE SALT | MLLT1, MEN1, MLLT3 | ACMSD 3387/4885CA1 4338/4885CA2 3166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.